PATENT CLAIM ANALYSIS

Application Number: 15884428
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "186100"]

Abstract:
A method of treating a subject having or at risk for having a virus infection, by administering to the subject a therapeutically effective amount of a composition comprising a vector encoding a CRISPR-associated endonuclease and at least two guide RNAs, wherein the guide RNAs are complementary to two target sequences spanning from the 5′- to 3′-LTRs of the sequence in the virus, and completely resolving the symptoms of a disease, decreasing the severity of the symptoms of the disease, or slowing the disease's progression.

Claim (Index 8):
The method of  claim 5 , wherein the virus is HIV-1, and the first spacer sequence and the second spacer sequence each include, respectively, a sequence complementary to the target protospacer sequences SEQ ID NO: 87 and SEQ ID NO: 110.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.71698
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14838057', '15148261', '14644181', '15127087', '15449181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75601705877565
- 35 USC 102 Novelty (BERT): 0.5797471180902944
- Combined Prediction Score: 0.7383900647071144
- Mean Citation Score: 406.35744
- Max Citation Score: 571.3226
- Similarity Product: 366.8039676870942

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test